Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Head & Neck
X XieM Boysen
Analytical and Quantitative Cytology and Histology
Patrícia Campos FontesJanete Dias Almeida
Pediatric Hematology and Oncology
Turkan PatirogluNalan Imamoglu
Ginekologia polska
Leszek GottwaldAndrzej Bieńkiewicz
American Journal of Obstetrics and Gynecology
Pascal AbboudDominique Ploton